How Much Weight Did You Lose on Ozempic?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When patients ask about Ozempic weight loss results, the clinical evidence is compelling: semaglutide reduced body weight by an average of 9.2 kg (20 pounds) in landmark trials, with sustained benefits when treatment continues. Understanding what these results actually mean for your body and health goals helps you make informed decisions about GLP-1 therapy.

Average Weight Loss on Semaglutide: What Clinical Trials Show

The STEP clinical trial program evaluated semaglutide's impact on weight loss across 16,000+ participants over three years. Patients receiving 2.4 mg weekly semaglutide lost between 10-15% of their starting body weight by week 68, compared to just 2-3% in the placebo group. This difference remained significant even after accounting for diet and exercise changes, demonstrating that semaglutide works through mechanisms beyond behavior modification alone.

Weight loss wasn't instantaneous; most patients experienced gradual, consistent reduction over the first 12-16 weeks as their bodies adjusted to the medication. The rate of loss typically peaked around month four to six, then stabilized as long as treatment continued. When patients stopped taking semaglutide, weight gradually returned, highlighting that ongoing therapy maintains results rather than producing permanent change.

Real-World Weight Loss Outcomes Beyond Clinical Trials

Real-world data from primary care clinics and weight management centers shows similar patterns to clinical trials, though outcomes vary based on starting weight, age, and adherence. Patients with a higher initial body mass index often experience greater absolute weight loss (more pounds), while those closer to a healthy weight see smaller but still clinically meaningful reductions. Consistency with weekly injections and modest dietary changes appear to be the strongest predictors of success across diverse patient populations.

Electronic health record reviews from major healthcare systems document that semaglutide users who remained on treatment for at least six months maintained 70-80% of their weight loss benefit. Dropout rates were highest in the first month due to nausea and appetite changes, but patients who continued past week four typically reported improved tolerability and sustained commitment. These real-world patterns closely mirror what clinical trials predicted about patient experience.

Factors That Influence Your Individual Weight Loss Results

Genetic variation plays an underestimated role in how your body responds to GLP-1 therapy. The FTO gene (rs9939609 variant) affects your baseline appetite regulation and how strongly semaglutide's appetite-suppressing effects will work in your system. The GLP1R gene (rs6923761) directly influences receptor sensitivity, meaning some people's bodies respond more dramatically to the same medication dose than others do.

Your starting weight, age, baseline metabolism, physical activity level, and dietary habits all shape the magnitude and timeline of weight loss. Someone starting at 250 pounds will lose more total pounds than someone starting at 180 pounds, but both may see similar percentage improvements. PlexusDx's Precision Peptide Genetic Test maps 14 pathways and identifies key variants like MC4R and GIPR to predict your personal response pattern before you start treatment.

PlexusDx Compounded Semaglutide: Same Mechanism, Direct Affordability

PlexusDx compounds semaglutide through licensed 503A pharmacies, delivering the identical active compound that produces those clinical trial results—starting at $149 per month with no insurance required, no membership fees, and HSA/FSA eligibility. The bioavailability and mechanism are equivalent to brand-name Ozempic; the difference is direct pharmacy compounding eliminates middleman markups that make branded versions unaffordable for many patients.

Your dose may need to go up as you progress through titration, but your price won't—PlexusDx pricing remains flat across all dose levels. If your genetic test suggests you'd benefit from dual-peptide therapy, the GLP-Squared injection combines semaglutide and tirzepatide starting at $249/month, offering flexibility as your treatment evolves. PlexusDx serves all 50 states and manages the full patient journey from genetic assessment through ongoing therapy support.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically expect to lose on semaglutide?

Clinical data shows average weight loss of 10-15% of body weight over 16-68 weeks, translating to roughly 15-30 pounds for someone starting at 200 pounds. Your individual result depends on genetics, starting weight, and treatment adherence. PlexusDx can use your Precision Peptide Genetic Test results to estimate your likely response category before you begin.

Does semaglutide produce permanent weight loss or do you regain it after stopping?

Semaglutide's weight loss is sustained only as long as you take the medication consistently. When patients stopped in clinical trials, weight gradually returned over several months. This is why GLP-1 therapy is best understood as long-term treatment rather than a quick fix—similar to how blood pressure medication works only while you take it.

Can I get semaglutide weight loss results without paying brand-name Ozempic prices?

Yes. PlexusDx compounded semaglutide injection from licensed 503A pharmacies delivers the same active ingredient and weight loss outcomes, starting at $149/month with no insurance needed. Your dose may need to go up as you progress, but PlexusDx pricing stays flat, making long-term therapy genuinely affordable.

What side effects happened to people in the weight loss trials?

The most common side effects were nausea, vomiting, and diarrhea—typically mild and transient in the first 2-4 weeks as your system adjusts. Serious adverse events were rare and comparable to placebo. Most patients who continued past the first month reported improving tolerability, and appetite suppression became the primary therapeutic effect rather than a side effect.

How does genetic testing help predict my semaglutide weight loss?

PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that predict how strongly your body will respond to semaglutide. These 4 key variants account for meaningful differences in appetite suppression strength and metabolic adaptation, allowing personalized dosing strategy from your first injection.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.